Smith Salley Wealth Management’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-7,308
Closed -$466K 264
2025
Q1
$466K Hold
7,308
0.03% 174
2024
Q4
$889K Buy
+7,308
New +$889K 0.06% 147